$4.36
0.081.87%
In chiusura: -
$4.25
-0.11-2.52%
After hour: 7:12 PM EDT
Tieni traccia delle ultime attività di insider trading Taysha Gene Therapies. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Taysha Gene Therapies.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Sep 12, 2025 | PRESIDENT AND HEAD R&D | -158.85K | $1.96 | -$617.24K | SELL | -13.63% | 1.01M | Sep 10 | ||
Aug 22, 2025 | PRESIDENT AND HEAD R&D | -57.05K | $2.85 | -$162.60K | SELL | -4.67% | 1.17M | Aug 21 | ||
Aug 22, 2025 | CHIEF FINANCIAL OFFICER | -54.49K | $2.85 | -$155.30K | SELL | -4.39% | 1.19M | Aug 21 | ||
Jun 03, 2025 | — | 750.00K | $2.75 | $2.06M | BUY | 12.31% | 6.84M | May 30 | ||
Jul 01, 2024 | — | 1.33M | $2.25 | $3.00M | BUY | 27.56% | 6.17M | Jun 27 | ||
Nov 20, 2023 | 10% OWNER | 100.00K | $1.63 | $163.00K | BUY | 0.47% | 21.40M | Nov 17 | ||
Aug 25, 2023 | CHIEF FINANCIAL OFFICER | -33.00K | $2.33 | -$76.89K | SELL | -11.34% | 258.04K | Aug 24 | ||
Aug 16, 2023 | 10% OWNER | 16.47M | $0.90 | $14.82M | BUY | 340.40% | 21.30M | Aug 16 | ||
Aug 16, 2023 | DIRECTOR | 827.78K | $0.90 | $700.00K | BUY | 373.54% | 1.05M | Aug 16 | ||
Aug 16, 2023 | CHIEF EXECUTIVE OFFICER | 444.44K | $0.90 | $400.00K | BUY | 40.69% | 1.54M | Aug 16 | ||
Aug 16, 2023 | DIRECTOR | 111.11K | $0.90 | $100.00K | BUY | 3703.70% | 114.11K | Aug 16 | ||
Jul 14, 2023 | — | -85.87K | $0.71 | -$60.77K | SELL | -0.94% | 9.01M | Jul 12 - Jul 13 | ||
Jun 26, 2023 | 10% OWNER | -28.61K | $0.70 | -$20.12K | SELL | -0.31% | 9.10M | Jun 22 - Jun 23 | ||
Jun 22, 2023 | 10% OWNER | -434.62K | $0.71 | -$307.84K | SELL | -4.55% | 9.13M | Jun 20 - Jun 21 | ||
May 18, 2023 | PRESIDENT AND HEAD R&D | 5.00K | $0.68 | $3.40K | BUY | 17.11% | 34.23K | May 16 | ||
Nov 02, 2022 | DIRECTOR | 1.50M | $2.00 | $3.00M | BUY | 44.95% | 4.84M | Oct 31 | ||
Aug 24, 2022 | CHIEF FINANCIAL OFFICER | -3.33K | $3.47 | -$11.54K | SELL | -1.23% | 266.12K | Aug 23 | ||
Aug 22, 2022 | CHIEF FINANCIAL OFFICER | -28.68K | $3.70 | -$106.00K | SELL | -9.62% | 269.45K | Aug 18 - Aug 22 | ||
Jul 07, 2022 | CMO AND HEAD R&D | -12.86K | $3.70 | -$47.65K | SELL | -2.37% | 530.59K | Jul 05 - Jul 06 | ||
Jul 01, 2022 | CMO AND HEAD R&D | -50.14K | $3.65 | -$183.08K | SELL | -8.45% | 543.45K | Jun 29 - Jul 01 | ||
Feb 04, 2022 | DIRECTOR | 201.60K | $7.80 | $1.57M | BUY | 3.96% | 5.29M | Feb 02 - Feb 03 | ||
Feb 03, 2022 | DIRECTOR | 10.00K | $8.01 | $80.10K | BUY | 52.01% | 29.23K | Feb 02 | ||
Feb 03, 2022 | DIRECTOR | 3.00K | $7.78 | $23.34K | BUY | ∞ | 3.00K | Feb 02 | ||
Dec 08, 2021 | PRESIDENT AND CEO | 42.52K | $12.44 | $529.10K | BUY | 0.46% | 9.33M | Nov 23 | ||
Nov 29, 2021 | DIRECTOR | 2.20K | $13.19 | $29.04K | BUY | 0.11% | 2.05M | Nov 24 | ||
Nov 24, 2021 | DIRECTOR | 20.00K | $12.54 | $250.80K | BUY | 0.98% | 2.05M | Nov 23 | ||
Aug 20, 2021 | CHIEF FINANCIAL OFFICER | -33.00K | $16.88 | -$557.02K | SELL | -9.97% | 298.12K | Aug 18 - Aug 20 | ||
Jul 01, 2021 | CMO AND HEAD R&D | -79.00K | $22.63 | -$1.79M | SELL | -11.75% | 593.59K | Jun 29 - Jul 01 | ||
May 24, 2021 | DIRECTOR | 1.17K | $22.35 | $26.15K | BUY | 0.11% | 1.09M | May 20 | ||
May 17, 2021 | DIRECTOR | 12.00K | $20.98 | $251.76K | BUY | 0.59% | 2.03M | May 14 |
Sfoglia insider trading su tutte le azioni.